Advertisement

Pediatric Surgery International

, Volume 12, Issue 8, pp 591–594 | Cite as

Does treatment with human chorionic gonadotropin induce reversible changes in undescended testes in boys?

  • S. Demirbilek
  • H. F. Atayurt
  • N. Çelik
  • G. Aydin
Original Article

Abstract

Between May 1993 and November 1995, 71 cryptorchid boys were treated with human chorionic gonadotropin (hCG); 42 were operated upon following unsuccesful hCG treatment. A routine orchiopexy was performed in each case. In 10 cases a testicular biopsy was made during orchipexy within 3 days following hCG treatment; in another 10 biopsies were taken 6 to 9 months after treatment. Testicular biosies were taken at the time of orchiopexy in 5 cryptorchid boys who were not treated with hCG as a control group. A mild, inflammation-like reaction was found in the cryptorchid testes in the period immediately following the last hCG injections, but those studied 6 to 9 months after the last injection there were no apparent such reactions. In contrast to the inflammation-like reaction, the volume density of blood vessels, interstitial bleeding, and diameter of the seminiferous tubules had not regressed. The numbers of spermatogonia per tubular transverse section and the percentage of tubular transverse sections containing spermatogonia (the fertility index) were increased.

Key words

Undescended testis Human chorionic gonadotropin treatment Testicular biopsy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bay V, Bierich JR, Hecker WC., et al (1974) Kleine Mitteilungen. Dtsch Med Wochenschr 98: 549Google Scholar
  2. 2.
    Berg A, Widmark A, Damber JE, et al (1986) Are leukocytes involved in the human chorionic gonadotropin induced increase in testicular vascular permeability. Endocrinology 119: 586–589PubMedGoogle Scholar
  3. 3.
    Berg A, Rooth P, Widmarks A, et al (1987) Treatment of rats with hCG induced inflammation-like changes in the testicular microcirculation. J Reprod Fert 79: 135–143Google Scholar
  4. 4.
    Bica TDG, Hadziselimovic F (1992) Buserelin treatment of cryptorchidism: a randomized, double blind, placebo controlled study. J Urol 148: 617–620PubMedGoogle Scholar
  5. 5.
    Bica TDG, Hadziselimovic F (1993) The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin. Eur J Pediatr 152 [Suppl 2]: 938Google Scholar
  6. 6.
    Christiansen P, Miller J, Buhl S, et al (1988) Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. Horm Res 30: 187–192PubMedGoogle Scholar
  7. 7.
    Cortes D (1990) Histological versus sterological methods applied at spermatogonia during normal human development. Scand J Urol Nephrol 24: 11–15PubMedGoogle Scholar
  8. 8.
    Damber JE, Berg A, Daehlin L (1985) Testicular blood flow, vascular permeability, and testosterone production after stimulation of unilaterally cryptorchid adult rats with human chorionic gonadotropin. Endocrinology 117: 1906–1913PubMedGoogle Scholar
  9. 9.
    Fonkalsrud EW (1986) Undescended testes. In Welch KJ, Randolph JG, Ravitch MM, O'Neil, Jr. JA, Rowe MI (eds) Pediatric surgery. Year Book Medical Publishers, Chicago, pp 793–807Google Scholar
  10. 10.
    Hadziselimovic F, Huff D, Duckett J, et al (1987) Long term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testis. J Urol 138: 1043–1045PubMedGoogle Scholar
  11. 11.
    Hjertkvist M, Berg A, Damber JE (1988) HCG treatment increases intratesticular pressure in the abdominal testis of unilaterally cryptorchid rats. J Androl 9: 116–120PubMedGoogle Scholar
  12. 12.
    Hjerkvist M, Läckgren G, Plöen L, et al (1993) Does hCG treatment induce inflammation-like changes in undescended testes in boys? J Pediatr Surg 28: 254–258PubMedGoogle Scholar
  13. 13.
    Kerr JB, Sharpe RM (1989) Focal disruption of spermatogenesis in the testis of adults rats after a single administration of human chorionic gonadotropin. Cell Tissue Res 257: 163–169PubMedGoogle Scholar
  14. 14.
    Lalo R, Motarazzo P, Chiabatto P, et al (1993) Combined therapy with LHRH and HCG in crypyorchid infants. Eur J Pediatr 152[Suppl 2]: 931PubMedGoogle Scholar
  15. 15.
    Leon MD, Chiauzzi VA, Caluo JC, et al (1987) Acute hCG administration induced seminiferous tubule damage in adult rats. Acta Physiol Pharmacol Latinoam 37: 277–288PubMedGoogle Scholar
  16. 16.
    Rojfer J, Handelsman DJ, Swerdlofg RS, et al (1986) Hormonal therapy of cryptorchidism: a randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin releasing hormone. N Eng J Med 314: 466–470Google Scholar
  17. 17.
    Rozanski TA, Bloom DA (1995) The undescended testis. Urol Clin North Am 22: 107–118PubMedGoogle Scholar
  18. 18.
    Sharpe RM (1984) Intratesticular factors controlling testicular function. Biol Reprod 30: 29–49PubMedGoogle Scholar
  19. 19.
    Urban MD, Lee PA, Lanes R, et al (1987) HCG stimulation in children with cryptorchidism. Clin Pediatr 26: 512–515Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • S. Demirbilek
    • 1
  • H. F. Atayurt
    • 1
  • N. Çelik
    • 2
  • G. Aydin
    • 1
  1. 1.Department of Pediatric Surgery and PathologySocial Security Council, Ankara Children's HospitalAnkaraTurkey
  2. 2.Department of PathologySocial Security Council Ankara Children's HosiptalAnkaraTurkey

Personalised recommendations